{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T10:23:35Z","timestamp":1772965415895,"version":"3.50.1"},"reference-count":68,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":4155,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p>Understanding of the role, triggers, and impact of the renin\u2010angiotensin\u2010aldosterone system in cardiovascular disease has significantly broadened. In recent years substantial discoveries have been made regarding the pathophysiology of heart failure, particularly in the area of neurohormonal activation. New interest in therapy with aldosterone antagonists was stimulated by results of a 2\u2010year study of 1663 patients with heart failure that showed a 30% relative risk reduction of death among patients given a subhemodynamic dosage of spironolactone, a nonselective aldosterone antagonist, compared with placebo, in addition to standard therapy of diuretics, angiotensin\u2010converting enzyme inhibitors, \u03b2\u2010blockers, and digitalis.<\/jats:p>","DOI":"10.1592\/phco.20.13.1107.35023","type":"journal-article","created":{"date-parts":[[2004,6,15]],"date-time":"2004-06-15T15:41:47Z","timestamp":1087314107000},"page":"1107-1115","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Aldosterone, a New Appreciation of Its Role in Heart Failure"],"prefix":"10.1002","volume":"20","author":[{"given":"Amy J.","family":"Cha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Malecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin W.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"640","volume-title":"Heart disease. a textbook of cardiovascular medicine","author":"Colucci WS","year":"1997"},{"key":"e_1_2_1_3_2","first-page":"1","volume-title":"2000 heart and stroke statistical update","author":"American Heart Association.","year":"1999"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410806"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.275.5.H1826"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.99.2.382"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00944787"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/28.5.684"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001090050182"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00877115"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960171107"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.72.5.422"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.4.704"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.25.3224"},{"key":"e_1_2_1_15_2","first-page":"F883","article-title":"Mechanism of sodium retention in heart failure: relation to the renin\u2010angiotensin\u2010aldosterone system","volume":"260","author":"Eiskjaer H.","year":"1991","journal-title":"Am J Physiol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90238-8"},{"issue":"13","key":"e_1_2_1_17_2","first-page":"2897","article-title":"Regulation of arterial pressure: role of pressure natriuresis and diuresis","volume":"45","author":"Hall JE","year":"1986","journal-title":"Fed Proc"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.27.4.906"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1099"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.5.1730"},{"key":"e_1_2_1_21_2","first-page":"88P","article-title":"Angiotensin II decreases, while captopril increases myocardial noradrenaline uptake: a mechanism for ACE inhibitors reducing cardiac death [abstr]","volume":"106","author":"Arnott M.","year":"1992","journal-title":"Br J Pharmacol"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90441-6"},{"issue":"1","key":"e_1_2_1_23_2","article-title":"Interactions of mineralocorticoids and pressor agents in vascular smooth muscle","volume":"5","author":"Weber MA","year":"1983","journal-title":"Hypertension"},{"key":"e_1_2_1_24_2","first-page":"P96","article-title":"Aldosterone blunts the reflex baroreceptor response to noradrenaline in healthy man [abstr]","volume":"71","author":"Barr CS","year":"1994","journal-title":"Br Heart J"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90633-7"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.0954-6820.1986.tb18112.x","article-title":"Intracellular electrolytes in cardiac failure","volume":"707","author":"Wester PO","year":"1986","journal-title":"Acta Med Scand"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.67.6.1355"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/26.7.671"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.6.1849"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.24.1.30"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117269"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.34.2.285"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.7.5.753"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_N.98"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00004-6"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1997.0157"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone. Biosynthesis and a link to angiotensin II\u2010induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama H.","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.2.170"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.9.4883"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90073-6"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00091-6"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90410-M"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90240-D"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_N.103"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(62)90021-8"},{"key":"e_1_2_1_46_2","first-page":"I","article-title":"The effect of a mineralocorticoid antagonist on myocardial mIBG uptake in congestive heart failure [abstr]","volume":"88","author":"Barr CS","year":"1993","journal-title":"Circulation"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.3.270"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.24.5.571"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.6.2026"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.3.772"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.21.6.929"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.6.594"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb03901.x"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199302000-00015"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0910457"},{"key":"e_1_2_1_56_2","first-page":"I","article-title":"Progression of left ventricular dysfunction during enalapril therapy, relationship with neuro\u2010hormonal reactivation [abstr]","volume":"88","author":"Pouleur H.","year":"1993","journal-title":"Circulation"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.52.5.530"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198211000-00014"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00877755"},{"key":"e_1_2_1_60_2","volume-title":"Aldactone (spironolactone) package insert","author":"Pharmacia.","year":"1999"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80353-1"},{"key":"e_1_2_1_62_2","first-page":"235","article-title":"Captopril and spironolactone therapy in patients with refractory congestive heart failure","volume":"51","author":"Dahlstrom U.","year":"1992","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1986.tb01119.x"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610103351504"},{"key":"e_1_2_1_68_2","volume-title":"Late\u2010breaking clinical trial results\u2014session III. PRAISE\u20102: Prospective Randomized Amlodipine Survival Evaluation","author":"Packer M.","year":"2000"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02213-3"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.20.13.1107.35023","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.20.13.1107.35023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:43:52Z","timestamp":1761065032000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.20.13.1107.35023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1592\/phco.20.13.1107.35023"],"URL":"https:\/\/doi.org\/10.1592\/phco.20.13.1107.35023","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}